The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27109867 |
48 |
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. |
Glaxosmithkline |
| 31265286 |
17 |
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[ |
Glaxosmithkline |
| 30344914 |
37 |
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel. |
Glaxosmithkline |
| 29057049 |
53 |
Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases. |
Genomics Institute of The Novartis Research Foundation |
Search and Browse
